semaglutide and alcohol consumption Tirzepatide reduce in individuals with obesity GLP-1 medications: The next big

Adding a drug on top of a program that is holding is a different decision from trading the program for the drug, and the second one is what the VA is warning about

The Patient Report includes patients without baseline prescription for or documented allergy to any SGLT2 inhibitor or GLP-1 RA

GSTK1 and RETREG1/FAM134B-mediated reticulophagy attenuates tubular injury in diabetic nephropathy through endoplasmic reticulum stress and apoptosis

Studies suggest up to half of users stop within a year, often because of cost, side effects or access issues

(63(6)):524-528 doi:10.1002/jmd2.12319

Prevalence and risk factors for dry eye syndrome